publication venue for Optimized Lower Dose Combinations of Sulindac Plus Erlotinib Sustained Antitumor Efficacy and Reduced Toxicity in a Preclinical Model of FAP 2021 Growth Hormone Normalizes Gastrointestinal Symptoms in mTBI Patients 2020
